Dale B. Schenk, PhD, a leader in the movement to treat neurodegenerative diseases with antibodies, died September 30. Co-founder, president and chief executive officer of biotech Prothena, Dr. Schenk’s contributions offered a new way to potentially treat Alzheimer's and Parkinson's diseases.

"Trying to cure complex brain diseases requires dedicated, out-of-the-box problem solvers," said Todd Sherer, PhD, CEO of The Michael J. Fox Foundation. "Dr. Schenk was one such innovator, and we are closer to a world without Parkinson's or Alzheimer's today because of him."

Read more about Dr. Schenk's legacy.

Image via Prothena